AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2039194
Drug: Temafloxacin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temafloxacin (all doses)
Trial: 6861436
Drug: Methadone doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone doses (0, 1, 5, 10, 25, or 50 mg)
Trial: 25014686
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin and 40 mg of laropiprant
Trial: 20196846
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics (penicillin V)
Trial: 31134657
Drug: Ketoconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (200 mg, twice daily for 5 days)
Trial: 10908773
Drug: Clindamycin 100
RxNorm normalized name: clindamycin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 100 mg vaginal ovules (intravaginally for 3 days) plus placebo capsules (orally twice daily for 7 days)
Trial: 10908773
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg (two 250 mg capsules orally twice daily for 7 days) plus placebo ovules (intravaginally for 3 days)
Trial: 10908773
Drug: Metronidazole treatment
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole treatment group
Trial: 3901562
Drug: Verapamil retard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil retard preparation 240 mg b.i.d.
Trial: 3901562
Drug: Nifedipine retard
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine retard preparation 20 mg b.i.d.
Trial: 28528340
Drug: Hypocaloric high‐protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocaloric high‐protein diet (1.2‐1.4 g / kg body weight reference / day)
Trial: 26169611
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg daily plus oral tivantinib 360 mg twice daily (E + T)
Trial: 21561900
Drug: AZD1305 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (50 mg/h)
Trial: 21561900
Drug: AZD1305 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (100 mg/h)
Trial: 21561900
Drug: AZD1305 (130
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (130 mg/h)
Trial: 21561900
Drug: AZD1305 (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD1305 (180 mg/h)
Trial: 11131366
Drug: Supplementation with
RxNorm normalized name: Similac For Supplementation with Iron Powder for Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementation with 1.7 g of EPA plus 1.15 g of DHA/day (as Maxepa capsules) for 28 days
Trial: 11131366
Drug: Supplementation with
RxNorm normalized name: Similac For Supplementation with Iron Powder for Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementation with Maxepa capsules
Trial: 7854376
Drug: Fluconazole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluconazole (200 mg per day)
Trial: 1727236
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (mean daily dose, 0.4 mg per kilogram of body weight in successful treatment; 0.5 mg per kilogram in treatment failure)
Trial: 26909669
Drug: Clopidogrel 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 150 mg daily
Trial: 22088980
Drug: Clopidogrel 225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 225 mg daily
Trial: 22088980
Drug: Clopidogrel 300
RxNorm normalized name: clopidogrel 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel 300 mg daily
Trial: 25138079
Drug: Intraoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiation therapy (IOERT) using electrons
Trial: 25138079
Drug: External beam
RxNorm normalized name: Beam
DrugBank: Tricyclazole (DB02891)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External beam radiation therapy (EBRT)
Trial: 25138079
Drug: Intraoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiation therapy (IORT) using 50-kV X-rays
Trial: 22235820
Drug: Lisinopril (n=8904)
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril (n=8904)
Trial: 19224415
Drug: Volar transposition
RxNorm normalized name: Polar Freeze
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volar transposition of the ulnar nerve (subcutaneous or submuscular technique)
Trial: 19224415
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment (prevention of exposure to external noxes)
Trial: 10771928
Drug: PRP‐T vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP‐T vaccine in association with DPT vaccine at different sites
Trial: 10771928
Drug: PRP‐T and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP‐T and DPT both vaccines at the same site mixed in the same syringe
Trial: 10771928
Drug: PRP‐T vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRP‐T vaccine
Trial: 2883715
Drug: terfenadine 60
RxNorm normalized name: terfenadine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terfenadine 60 mg twice daily
Trial: 2883715
Drug: dexchlorpheniramine 6
RxNorm normalized name: dexchlorpheniramine 6 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexchlorpheniramine 6 mg twice daily
Trial: 30897999
Drug: Diabetes mellitus
RxNorm normalized name: diagnostic,monitoring agents for diabetes mellitus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes mellitus requiring treatment
Trial: 27701683
Drug: Saffron (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron (30 mg/day)
Trial: 15812262
Drug: Citalopram (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram (40 mg/day)
Trial: 21493022
Drug: Estrogen therapy-aerobic
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy-aerobic training (ET-AT)
Trial: 23942244
Drug: Estrogen therapy-control
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen therapy-control
Trial: 22769041
Drug: Augmented Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented Cognitive Behavioural Therapy (CBT) intervention, which includes principles of recognizing, registering, and altering negative thoughts, augmented with direct in-vivo activation by occupational or movement therapists.
Trial: 19640972
Drug: High cruciferous
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High cruciferous vegetable diet (14 g cruciferous vegetables/(kg body weightd))
Trial: 10379619
Drug: Zolpidem (5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (5, 10, 20 mg/70 kg)
Trial: 10379619
Drug: Triazolam (0.125,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.125, 0.25, 0.5 mg/70 kg)
Trial: 8537264
Drug: Dirithromycin, 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dirithromycin, 500 mg once daily for 5 days
Trial: 8537264
Drug: Clarithromycin, 250
RxNorm normalized name: Clarithromycin, 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin, 250 mg twice daily for 7 days
Trial: 28818674
Drug: Electroacupuncture (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture (EA) administered 24 hours prior to surgery
Trial: 26428278
Drug: Palm date
RxNorm normalized name: date palm pollen extract
DrugBank: Phoenix dactylifera pollen (DB10950)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palm date consumption (seven dates, approximately 50 g)
Trial: 26428278
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maltodextrin‐dextrose, 37·1 g)
Trial: 23434504
Drug: Intranasal insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal insulin (40 IU 4 times per day)
Trial: 21287538
Drug: Boswellia serrata
RxNorm normalized name: Boswellia Serrata
DrugBank: Indian frankincense (DB14275)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Boswellia serrata (BS) 4200 mg/day
Trial: 23579010
Drug: Cardiac Resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Trial: 10893915
Drug: Breastfeeding support
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breastfeeding support including anticipatory counseling and monthly clinical follow-up
Trial: 1342280
Drug: Nutrition supplements
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrition supplements (calcium, magnesium, potassium, fish oil)
Trial: 31535213
Drug: 136.6 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 136.6 mg isoflavones (as aglycone equivalents)
Trial: 30466866
Drug: EPA (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (2 g per day)
Trial: 30466866
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg per day)
Trial: 30466866
Drug: EPA plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA plus Aspirin
Trial: 24071754
Drug: CRAFT family
RxNorm normalized name: polyvinyl alcohol graft polyethylene glycol copolymer (3:1; 45000 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CRAFT family education program (6 weekly 2 hour sessions)
Trial: 20160396
Drug: Non-statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-statin treatment
Trial: 10895748
Drug: i.m. ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. ketamine 0.5-0.6 mg kg-1
Trial: 10895748
Drug: i.m. morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. morphine 0.1-0.15 mg kg-1
Trial: 4076532
Drug: Cimetropii bromidum
RxNorm normalized name: Clidinii Bromidum
DrugBank: Clidinium (DB00771)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cimetropii bromidum (10 or 20 mg i.v.)
Trial: 29664851
Drug: Formal outpatient
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formal outpatient physical therapy (PT)
Trial: 20582493
Drug: T8 floating
RxNorm normalized name: T8 Keto Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T8 floating tablets
Trial: 20582493
Drug: Immediate-release tablets
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release tablets (Vastrel® 20 mg)
Trial: 3937005
Drug: Tocainide infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocainide infusion
Trial: 3937005
Drug: Oral tocainide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral tocainide therapy
Trial: 30761795
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel (Androgel) at a daily dose of 5 g (1 sachet)
Trial: 30761795
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel (Androgel) at a daily dose of 10 g (2 sachets)
Trial: 30761795
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy (exercise, diet, multivitamins)
Trial: 27571129
Drug: Triple intrathecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple intrathecal therapy (TIT)
Trial: 21083596
Drug: rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 10 mg/day
Trial: 24121146
Drug: rabeprazole 5
RxNorm normalized name: RABEprazole 5 mg oral delayed release capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rabeprazole 5 mg
Trial: 18501262
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg daily of the SSRI antidepressant paroxetine
Trial: 10475292
Drug: Neostigmine 2.5
RxNorm normalized name: neostigmine 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine 2.5 mg i.v. and glycopyrrolate 0.5 mg i.v. for reversal of residual neuromuscular blockade
Trial: 10475292
Drug: No neostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No neostigmine administration
Trial: 8542854
Drug: Bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine plus buprenorphine (7.2 mg kg‐1 of buprenorphine with 1.8 mg kg‐1 of bupivacaine)
Trial: 8542854
Drug: Bupivacaine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine alone (1.8 mg kg‐1)
Trial: 28481967
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus bevacizumab at randomization
Trial: 28481967
Drug: Chemotherapy followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chemotherapy followed by bevacizumab after disease progression (PD)
Trial: 22563991
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health promotion activities (intervention)
Trial: 21282542
Drug: Erlotinib 150
RxNorm normalized name: erlotinib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib 150 mg/d
Trial: 16899475
Drug: oral oestradiol‐17beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral oestradiol‐17beta 1 mg plus norethisterone acetate 0.5 mg daily
Trial: 14976888
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of clomiphene and Chinese drugs for nourishing Shen and activating blood circulation (NSABC)
Trial: 7636533
Drug: Acitretin 30
RxNorm normalized name: Acitretin
DrugBank: Acitretin (DB00459)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acitretin 30 mg/d for 6 months
Trial: 31350938
Drug: Hochu-ekki-to (HET)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hochu-ekki-to (HET) 7.5 g oral per day, n = 9
Trial: 28379607
Drug: Autologous skin
RxNorm normalized name: Autologous skin culture
DrugBank: Autologous skin culture (DB18524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous skin cell suspension plus hydrocolloid dressings
Trial: 28379607
Drug: Autologous skin
RxNorm normalized name: Autologous skin culture
DrugBank: Autologous skin culture (DB18524)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous skin cell suspension
Trial: 21744377
Drug: Duloxetine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (mean 78.7 mg/day)
Trial: 19760046
Drug: Traditional oral
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional oral feeding (TOF)
Trial: 17893385
Drug: Self‐administered questionnaire
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self‐administered questionnaire
Trial: 9215820
Drug: Droloxifene (DRO)
RxNorm normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droloxifene (DRO) as first-line hormone therapy (HT)
Trial: 8459456
Drug: Piperacillin (4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin (4.5 g, every 6 hours)
Trial: 8459456
Drug: Gentamicin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin (80 mg, every 8 hours) and Metronidazole (500 mg every 6 hours)
Trial: 2943309
Drug: Paroxetine 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 15 mg
Trial: 1836894
Drug: Paroxetine 30
RxNorm normalized name: PARoxetine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 30 mg
Trial: 2943309
Drug: Paroxetine 30
RxNorm normalized name: PARoxetine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 30 mg (morning administration)
Trial: 20814324
Drug: Nicotine (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (8 mg) gum
Trial: 10215751
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of recombinant human growth hormone (rhGH)
Trial: 16383035
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of isotonic saline (placebo control)
Trial: 11896746
Drug: Active medication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medication (Potassium bromide 1X, Sodium bromide 2X, Nickel sulfate 3X, Sodium chloride 6X)
Trial: 10554537
Drug: Selenium and
RxNorm normalized name: Selenium and/or selenium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium and vitamin E as antioxidants in addition to standard therapy
Trial: 10554537
Drug: Reference group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference group with no additional therapy
Trial: 7481869
Drug: Dose-intensive regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-intensive regimen incorporating two courses of carboplatin
Trial: 7481869
Drug: High-dose carboplatin/cyclophosphamide/mitoxantrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose carboplatin/cyclophosphamide/mitoxantrone
Trial: 7481869
Drug: High-dose cisplatin/cyclophosphamide/thiotepa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cisplatin/cyclophosphamide/thiotepa
Trial: 7462674
Drug: 0.1% beta‐methasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% beta‐methasone 17‐valerate cream
Trial: 7462674
Drug: cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cream base
Trial: 7462674
Drug: clobetasone butyrate
RxNorm normalized name: clobetasone butyrate
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: clobetasone butyrate 0.05% cream
Trial: 7462674
Drug: hydrocortisone 1%
RxNorm normalized name: HYDROCORTISONE 1% OINT
DrugBank: Hydrocortisone acetate (DB14539)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: hydrocortisone 1% cream
Trial: 23820460
Drug: Tolvaptan administered
RxNorm normalized name: Tolvaptan
DrugBank: Tolvaptan (DB06212)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tolvaptan administered via nasogastric tube (crushed tablet in suspension)
Trial: 23820460
Drug: Tolvaptan tablets
RxNorm normalized name: Tolvaptan Tablets
DrugBank: Tolvaptan (DB06212)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tolvaptan tablets swallowed intact (oral administration)
Trial: 23204686
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg followed by intravaginal misoprostol 600 μg and 400 μg every 3 hours up to 5 doses
Trial: 23204686
Drug: Misoprostol alone
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol alone (600 μg followed by 400 μg every 3 hours up to 5 doses)
Trial: 9928923
Drug: Clozapine +
RxNorm normalized name: Clozapine
DrugBank: Clozapine (DB00363)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clozapine + Paroxetine (20 mg)
Trial: 9928923
Drug: Clozapine (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (2.5 mg/kg)
Trial: 2556978
Drug: IgG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG treatment (500 mg/kg, 12 weekly infusions)
Trial: 2556978
Drug: IgG treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgG treatment
Trial: 18191528
Drug: Preoperative chemoradiation
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative chemoradiation therapy (CRT)
Trial: 1595998
Drug: Aminophylline (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (6 mg/kg loading dose over 20 min, followed by 0.9 mg/kg/h maintenance infusion)
Trial: 6372707
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg artificial surfactant in 1 ml saline
Trial: 25127011
Drug: Alendronate discontinuation
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate discontinuation (placebo)
Trial: 18358540
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 200 mg/day over 8 weeks
Trial: 18358540
Drug: Lithium (Li)
DrugBank: Lithium succinate (DB14508)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium (Li) at least 900 mg/day over 2 weeks (serum level 0.6-1.2 mEq/L)
Trial: 1710009
Drug: Aprotinin (Trasylol)
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aprotinin (Trasylol) high dosage (about 800 mg) during extracorporeal circulation
Trial: 7224261
Drug: Cephalexin (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin (250 mg orally q.i.d. x 5 days)
Trial: 25501100
Drug: OPCAB with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OPCAB with BMC treatment
Trial: 23510529
Drug: Fluoxetine (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (10-20 mg/day) plus vitamin C (1000 mg/day)